VANGUARD GROUP INC - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$3,638,866
-31.2%
1,716,446
+0.2%
0.00%
Q2 2023$5,291,567
-37.7%
1,712,481
+8.4%
0.00%
Q1 2023$8,496,623
+7.2%
1,579,298
+32.6%
0.00%
Q4 2022$7,922,344
+202.8%
1,191,330
+81.3%
0.00%
Q3 2022$2,616,000
-19.9%
657,1420.0%0.00%
Q2 2022$3,266,000
-18.1%
657,142
-0.5%
0.00%
Q1 2022$3,989,000
-63.9%
660,447
-30.6%
0.00%
Q4 2021$11,064,000
-45.8%
952,126
-26.8%
0.00%
-100.0%
Q3 2021$20,400,000
+29.7%
1,301,056
+54.3%
0.00%
Q2 2021$15,728,000
-54.8%
843,383
+4.6%
0.00%
-100.0%
Q1 2021$34,763,000806,5620.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$34,226,0708.75%
OUP Management Co., LLC 374,714$2,015,9614.02%
Paradigm Biocapital Advisors LP 6,477,999$34,851,6353.30%
RA Capital Management 22,748,880$122,388,9742.77%
JOHNSON & JOHNSON 1,074,658$5,781,6601.88%
Artal Group S.A. 2,792,805$15,0250.89%
Trustees of Columbia University in the City of New York 91,910$494,4760.88%
Sarissa Capital Management LP 618,000$3,324,8400.42%
Laurion Capital Management LP 3,182,889$17,123,9430.12%
Woodline Partners LP 1,111,123$5,977,8420.08%
View complete list of VOR BIOPHARMA INC shareholders